We leave a hard and challenging year behind, a year in which we have suffered a great impact due to the decrease in the supply of our main products based on cough and cold relief. A year in which we have been able to learn great lessons, a year that has strengthened the values and pillars of our company, reinforcing our flexibility and creativity and that has let us implement several plans and processes that will undoubtedly set the course of our near future.

This has only been possible thanks to the great and full dedicated team that builds up Geiser Pharma from the shareholders, who have opted to continue investing in people and projects despite the difficulties caused by the pandemic, to each person in my team who has fought every day to reach the goals and to satisfy our customers’ requirements.

Special thanks also to our suppliers, for their flexibility and for managing and getting used to our urgent requests, and to our customers for trusting us every day in spite of the situation; this has allowed us to sign 34 new contracts and close 2 strategic alliances within this period.

Now, it is time for us to put all our enthusiasm and willingness to work together in order to reach the goals we have set out in our new strategic plan for the coming years 2022-2025. Geiser Pharma has now a lot of incredible and exciting challenges and we certainly count on all of you.

Thank you for trusting Geiser Pharma.